Investment approach

Holta Life Sciences is a young, but ambitious specialist investor in the life sciences sector.

We focus entirely on investments in the life sciences industry as we believe this sector has very favourable fundamentals.

In our view, the pace of innovation and success rates in development are set to rise based on a better understanding of molecular- and human biology and improved research tools.

Cost pressures in the healthcare system will, however, increase accordingly and hence we seek to identify companies that are developing products with:

  • potential to address clear unmet medical needs
  • significant market opportunities
  • strong IP- or orphan drug protection
  • substantial health economic benefits

We know the value of people, and hence we are actively contributing to identifying the right management team and board members in the companies in which we invest.

Holta Life Sciences is not dependent on external financing and consequently we have a longer-term perspective than most other investors.

We invest in product companies at all stages of development.

Our main focus areas are therapeutics, diagnostics and medical equipment.